Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study

Abstract Background The detection rate of methylated Septin9 (mSEPT9) in colorectal cancer (CRC) is varied greatly across the studies. This study aimed to evaluate the diagnostic ability of mSEPT9 in CRC, and compare the diagnostic efficacy with fecal immunochemical test (FIT). Methods 326 subjects...

Full description

Bibliographic Details
Main Authors: Dong-cheng Lu, Qi-fang Zhang, Li Li, Xian-ke Luo, Bin Liang, Yi-han Lu, Bang-li Hu, Hai-xing Jiang
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-022-02313-x
_version_ 1818203743424872448
author Dong-cheng Lu
Qi-fang Zhang
Li Li
Xian-ke Luo
Bin Liang
Yi-han Lu
Bang-li Hu
Hai-xing Jiang
author_facet Dong-cheng Lu
Qi-fang Zhang
Li Li
Xian-ke Luo
Bin Liang
Yi-han Lu
Bang-li Hu
Hai-xing Jiang
author_sort Dong-cheng Lu
collection DOAJ
description Abstract Background The detection rate of methylated Septin9 (mSEPT9) in colorectal cancer (CRC) is varied greatly across the studies. This study aimed to evaluate the diagnostic ability of mSEPT9 in CRC, and compare the diagnostic efficacy with fecal immunochemical test (FIT). Methods 326 subjects from four centers were prospectively recruited, including 179 CRC and 147 non-CRC subjects. The plasma was collected for mSEPT9 and CEA, AFP, CA125, CA153 and CA199 test, and fecal samples for FIT tests. Sensitivity, specificity and area under the curve (AUC) of receiver operating characteristic curve were calculated to evaluate the diagnostic value of each biomarker. Results The positive rate in mSEPT9 and FIT, and the level of CEA, CA125 and CA199 were significantly higher in CRC compared with non-CRC subjects. The mSEPT9 positive rate was not associated with TNM stage and tumor stage. The sensitivity, specificity and AUC of mSEPT9 in diagnostic CRC were 0.77, 0.88 and 0.82, respectively, while the value in FIT was 0.88, 0.80 and 0.83, respectively. mSEPT9 and FIT have higher AUC value than that of CEA, CA125 and CA199. Combination of both mSEPT9 and FIT positive increased sensitivity and AUC to 0.98 and 0.83, respectively, but the specificity was declined. mSEPT9 has a slightly low sensitivity in diagnosis of colon cancer (0.87) compared with rectal cancer (0.93). Conclusion mSEPT9 demonstrated moderate diagnostic value in CRC detection, which was similar to the FIT but superior to the CEA, CA125 and CA199. Combination of mSEPT9 and FIT further improved diagnostic sensitivity in CRC. Trial registration: ChiCTR2000038319.
first_indexed 2024-12-12T03:30:12Z
format Article
id doaj.art-928a99056134483488b7c22c8341a639
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-12T03:30:12Z
publishDate 2022-05-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-928a99056134483488b7c22c8341a6392022-12-22T00:39:56ZengBMCBMC Gastroenterology1471-230X2022-05-012211910.1186/s12876-022-02313-xMethylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter studyDong-cheng Lu0Qi-fang Zhang1Li Li2Xian-ke Luo3Bin Liang4Yi-han Lu5Bang-li Hu6Hai-xing Jiang7Department of Gastroenterology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Gastroenterology, Nanxishan Hospital of Guangxi Zhuang Autonomous RegionDepartment of Gastroenterology, Jiangbin Hospital of Guangxi Zhuang Autonomous RegionDepartment of Gastroenterology, Minzu Hospital of Guangxi Zhuang Autonomous RegionDepartment of Gastroenterology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Gastroenterology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Research, Guangxi Medical University Cancer HospitalDepartment of Gastroenterology, First Affiliated Hospital of Guangxi Medical UniversityAbstract Background The detection rate of methylated Septin9 (mSEPT9) in colorectal cancer (CRC) is varied greatly across the studies. This study aimed to evaluate the diagnostic ability of mSEPT9 in CRC, and compare the diagnostic efficacy with fecal immunochemical test (FIT). Methods 326 subjects from four centers were prospectively recruited, including 179 CRC and 147 non-CRC subjects. The plasma was collected for mSEPT9 and CEA, AFP, CA125, CA153 and CA199 test, and fecal samples for FIT tests. Sensitivity, specificity and area under the curve (AUC) of receiver operating characteristic curve were calculated to evaluate the diagnostic value of each biomarker. Results The positive rate in mSEPT9 and FIT, and the level of CEA, CA125 and CA199 were significantly higher in CRC compared with non-CRC subjects. The mSEPT9 positive rate was not associated with TNM stage and tumor stage. The sensitivity, specificity and AUC of mSEPT9 in diagnostic CRC were 0.77, 0.88 and 0.82, respectively, while the value in FIT was 0.88, 0.80 and 0.83, respectively. mSEPT9 and FIT have higher AUC value than that of CEA, CA125 and CA199. Combination of both mSEPT9 and FIT positive increased sensitivity and AUC to 0.98 and 0.83, respectively, but the specificity was declined. mSEPT9 has a slightly low sensitivity in diagnosis of colon cancer (0.87) compared with rectal cancer (0.93). Conclusion mSEPT9 demonstrated moderate diagnostic value in CRC detection, which was similar to the FIT but superior to the CEA, CA125 and CA199. Combination of mSEPT9 and FIT further improved diagnostic sensitivity in CRC. Trial registration: ChiCTR2000038319.https://doi.org/10.1186/s12876-022-02313-xColorectal cancerSeptin9MethylationFecal immunochemical testDiagnosis
spellingShingle Dong-cheng Lu
Qi-fang Zhang
Li Li
Xian-ke Luo
Bin Liang
Yi-han Lu
Bang-li Hu
Hai-xing Jiang
Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
BMC Gastroenterology
Colorectal cancer
Septin9
Methylation
Fecal immunochemical test
Diagnosis
title Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
title_full Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
title_fullStr Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
title_full_unstemmed Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
title_short Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
title_sort methylated septin9 has moderate diagnostic value in colorectal cancer detection in chinese population a multicenter study
topic Colorectal cancer
Septin9
Methylation
Fecal immunochemical test
Diagnosis
url https://doi.org/10.1186/s12876-022-02313-x
work_keys_str_mv AT dongchenglu methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT qifangzhang methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT lili methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT xiankeluo methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT binliang methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT yihanlu methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT banglihu methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy
AT haixingjiang methylatedseptin9hasmoderatediagnosticvalueincolorectalcancerdetectioninchinesepopulationamulticenterstudy